
DermTech is a diagnostics & research business based in the US. DermTech shares (DMTK) are listed on the NASDAQ and all prices are listed in US Dollars. DermTech employs 255 staff and has a trailing 12-month revenue of around $14.7 million.
How to buy DermTech stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – DMTK. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Trade stocks and ETFs for $0 and no annual fee
- Minimum deposit of $10 required
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
DermTech stock price (NASDAQ: DMTK)
Use our graph to track the performance of DMTK stocks over time.DermTech shares at a glance
Latest market close | $5.52 |
---|---|
52-week range | $1.55 - $16.33 |
50-day moving average | $2.94 |
200-day moving average | $5.18 |
Wall St. target price | $7.83 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-3.16 |
Buy DermTech stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy DermTech stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
DermTech price performance over time
Historical closes compared with the close of $5.52 from 2023-02-01
1 week (2023-01-27) | -10.97% |
---|---|
1 month (2022-12-30) | N/A |
3 months (2022-11-01) | 70.90% |
6 months (2022-08-02) | -33.97% |
1 year (2022-02-03) | -54.23% |
---|---|
2 years (2021-02-03) | -87.78% |
3 years (2020-02-03) | 12.91 |
5 years (2018-01-30) | N/A |
DermTech financials
Revenue TTM | $14.7 million |
---|---|
Gross profit TTM | $1.3 million |
Return on assets TTM | -31.16% |
Return on equity TTM | -56.28% |
Profit margin | 0% |
Book value | $5.13 |
Market capitalisation | $165.9 million |
TTM: trailing 12 months
DermTech share dividends
We're not expecting DermTech to pay a dividend over the next 12 months.
Have DermTech's shares ever split?
DermTech's shares were split on a 1:2 basis on 29 August 2019. So if you had owned 2 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your DermTech shares – just the quantity. However, indirectly, the new 100% higher share price could have impacted the market appetite for DermTech shares which in turn could have impacted DermTech's share price.
DermTech share price volatility
Over the last 12 months, DermTech's shares have ranged in value from as little as $1.55 up to $16.33. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DermTech's is 1.7606. This would suggest that DermTech's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
DermTech overview
DermTech, Inc. , a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc.
DermTech in the news

DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

DermTech Adds Approximately 1.2 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT)
This Under-the-Radar Stock Has Tripled in 2023 -- and Could Have More Room to Run
Frequently asked questions
What percentage of DermTech is owned by insiders or institutions?Currently 8.194% of DermTech shares are held by insiders and 41.094% by institutions. How many people work for DermTech?
Latest data suggests 255 work at DermTech. When does the fiscal year end for DermTech?
DermTech's fiscal year ends in December. Where is DermTech based?
DermTech's address is: 11099 North Torrey Pines Road, La Jolla, CA, United States, 92037 What is DermTech's ISIN number?
DermTech's international securities identification number is: US24984K1051 What is DermTech's CUSIP number?
DermTech's Committee on Uniform Securities Identification Procedures number is: G2379F124
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert